Journal article

Oncocytic Adrenocortical Neoplasm with Concomitant Papillary Thyroid Cancer.

  • Podetta M Department of Visceral Surgery, University Hospitals of Geneva, Geneva, Switzerland.
  • Pusztaszeri M Department of Clinical Pathology, University Hospitals of Geneva, Geneva, Switzerland.
  • Toso C Department of Visceral Surgery, University Hospitals of Geneva, Geneva, Switzerland.
  • Procopiou M Private Practice, Endocrinologist, Neuchâtel, Switzerland.
  • Triponez F Department of Thoracic and Endocrine Surgery, University Hospitals of Geneva, Geneva, Switzerland.
  • Sadowski SM Department of Thoracic and Endocrine Surgery, University Hospitals of Geneva, Geneva, Switzerland.
Show more…
  • 2018-02-07
Published in:
  • Frontiers in endocrinology. - 2017
English Adrenal oncocytoma (AO) is an extremely rare adrenocortical neoplasm and little is known about its malignant potential, secretory properties, and hereditary origin. We present the case of a benign AO with concomitant incidentally found papillary thyroid cancer (PTC) and review similar cases in the literature. Immunohistochemistry and next-generation sequencing (NGS) were performed. A 66-year-old women was incidentally found to have a large, androgen-secreting right adrenal mass. 18F-Fluorodeoxyglucose positron emission tomography showed intense uptake (SUVmax 88.7) of this mass and found a hypermetabolic right thyroid mass. Open adrenalectomy was performed for this highly suspicious adrenal mass. Histopathology revealed benign AO that was BRAFV600E negative, with low Ki-67, and no somatic mutation found on NGS. Thyroidectomy revealed invasive, BRAFV600E-positive PTC. At 6 months follow-up, androgen levels returned to normal, and no recurrence was seen on imaging. To our knowledge, this is the first report of an androgen-secreting AO with concomitant PTC. Possibly the simultaneous discovery of two independent neoplasms was observed. In conclusion, this case highlights that care should be given to exclude concomitant neoplasms. Long-term and regular imaging with biochemical follow-up is warranted, since the outcome and clinical behavior of AO remains uncertain.
Language
  • English
Open access status
gold
Identifiers
Persistent URL
https://folia.unifr.ch/global/documents/46517
Statistics

Document views: 61 File downloads:
  • Full-text: 0